Fueling the Next AI Unicorns with Web3
The future of AI isn’t just about tech—it’s about adoption. We give AI startups an instant go-to-market strategy, transforming them into viral ecosystems powered by Web3.
Featured Startups
Apex AI’s artificial intelligence delivers unprecedented accuracy (95%+) in identifying early-stage gastrointestinal (GI) cancers. Developed in partnership with Korea’s leading institutions, including Seoul National University Bundang Hospital and the Catholic University of Korea, and trained on over 1 million GI endoscopy images, Apex AI empowers doctors with early, life-saving cancer detection.
Early detection dramatically improves patient survival rates. After anticipated KFDA approval in 2025, Apex AI’s solution will rapidly scale across 1,400+ Korean hospitals and clinics via its partnership with iKooB. FDA approval aimed for 2026, opening doors to the U.S. market.
Coming soon
MySmaX’s patented, cloud-free JOI operating system seamlessly orchestrates every layer of a smart environment—from robotic assistants that cook, clean, and secure the home to coordinated drone swarms and intelligent building controls.
By running locally, JOI delivers instant automation and unmatched data privacy, turning complex robotics and IoT stacks into frictionless, everyday experiences. Smart living that once felt like science fiction is now within reach.
Coming soon
PurpleTalk’s AI-driven Early Autism Test System (EATS) enables pediatricians to deliver accurate, objective autism diagnoses in just two minutes. EATS is supported by research from Massachusetts General Hospital —a Harvard Medical School affiliate—and achieves a remarkable 92% accuracy rate.
Early, reliable diagnosis enables life-changing intervention during the crucial early childhood years. PurpleTalk’s technology empowers healthcare providers to swiftly and confidently diagnose autism, fundamentally transforming outcomes for children and families.